Astria Therapeutics, Inc.
Biotechnology ResearchMassachusetts, United States51-200 Employees
Astria Therapeutics, Inc. was acquired by BioCryst Pharmaceuticals, Inc. Please follow BioCryst Pharmaceuticals, Inc. for the latest news and updates.
Insights
Recent Acquisition Astria Therapeutics is currently in the process of being acquired by BioCryst Pharmaceuticals in a substantial deal valued at $700 million, indicating a significant shift in corporate strategy and potential expansion of product pipelines.
Emerging Market Presence The launch of Astria's hereditary angioedema medicine, ORLADEYO, in Portugal demonstrates a readiness to expand into international markets, offering sales opportunities across Europe.
Financial Stability With a revenue range between $50M and $100M and funding of $125M, the company shows solid financial backing, providing capacity for further research, development, and sales efforts.
Industry Engagement Astria's active participation in major healthcare conferences and events indicates a strategic push to increase visibility and foster relationships with key industry stakeholders for potential collaborations.
Technological Tools Utilization of advanced tech platforms such as SAP, Adobe Creative Cloud, and modern CMS systems suggests a modernized infrastructure, supporting efficient customer outreach and engagement strategies.
Similar companies to Astria Therapeutics, Inc.
Amunix
$10M$25MApellis Pharmaceuticals
$250M$500MExicure
$1M$10MAdverum Biotechnologies, Inc.
$1M$10MAUM Biosciences
$1M$10MAffinia Therapeutics
$10M$25MAavogen
$1M$10M
Astria Therapeutics, Inc. Tech Stack
Astria Therapeutics, Inc. uses 8 technology products and services including Adobe Creative Cloud, Concrete CMS, SAP, and more. Explore Astria Therapeutics, Inc.'s tech stack below.
- Adobe Creative CloudAudio, Video, Graphics
- Concrete CMSContent Management System
- SAPCustomer Relationship Management
- ModernizrJavascript Libraries
- List.jsJavascript Libraries
- Acquia Cloud Site FactoryWeb Hosting
- NginxWeb Servers
- FacebookWidgets
Media & News
Astria Therapeutics, Inc.'s Email Address Formats
Astria Therapeutics, Inc. uses at least 2 format(s):
| Astria Therapeutics, Inc. Email Formats | Percentage |
| FLast@catabasis.com | 75% |
| Last@catabasis.com | 24% |
| FMLast@catabasis.com | 1% |
| FLast@biocryst.com | 79% |
| First_Last@biocryst.com | 12% |
| First@biocryst.com | 7% |
| First.Last@biocryst.com | 2% |
Frequently Asked Questions
Where is Astria Therapeutics, Inc.'s headquarters located?
Astria Therapeutics, Inc.'s main headquarters is located at 22 Boston Wharf Road Floor 10 Boston, Massachusetts United States. The company has employees across 3 continents, including North AmericaEuropeAsia. What is Astria Therapeutics, Inc.'s phone number?
You can contact Astria Therapeutics, Inc.'s main corporate office by phone at +1-617-349-****
What is Astria Therapeutics, Inc.'s stock symbol?
Astria Therapeutics, Inc. is a publicly traded company; the company's stock symbol is ATXS. What is Astria Therapeutics, Inc.'s official website and social media links?
Astria Therapeutics, Inc.'s official website is biocryst.com and has social profiles on LinkedInCrunchbase.What is Astria Therapeutics, Inc.'s SIC code NAICS code?
Astria Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Astria Therapeutics, Inc. have currently?
As of March 2026, Astria Therapeutics, Inc. has approximately 100 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Commercial Officer (cco): A. K.Chief Medical Officer: C. M.Chief Human Resources Officer: K. M.. Explore Astria Therapeutics, Inc.'s employee directory with LeadIQ.What industry does Astria Therapeutics, Inc. belong to?
Astria Therapeutics, Inc. operates in the Biotechnology Research industry. What technology does Astria Therapeutics, Inc. use?
Astria Therapeutics, Inc.'s tech stack includes Adobe Creative CloudConcrete CMSSAPModernizrList.jsAcquia Cloud Site FactoryNginxFacebook. What is Astria Therapeutics, Inc.'s email format?
Astria Therapeutics, Inc.'s email format typically follows the pattern of FLast@catabasis.com. Find more Astria Therapeutics, Inc. email formats with LeadIQ. How much funding has Astria Therapeutics, Inc. raised to date?
As of March 2026, Astria Therapeutics, Inc. has raised $125M in funding. The last funding round occurred on Jan 30, 2024 for $125M.
Company Overview
- Headquarters
- 22 Boston Wharf Road Floor 10 Boston, Massachusetts United States
- Phone number
- +1-617-349-****
- Website
- biocryst.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- ATXS
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 51-200
Media & News
Funding & Financials
- $125M
Astria Therapeutics, Inc. has raised a total of $125M of funding over 17 rounds. Their latest funding round was raised on Jan 30, 2024 in the amount of $125M.
- $50M$100M
Astria Therapeutics, Inc.'s revenue is estimated to be in the range of $50M$100M
Funding & Financials
- $125M
Astria Therapeutics, Inc. has raised a total of $125M of funding over 17 rounds. Their latest funding round was raised on Jan 30, 2024 in the amount of $125M.
- $50M$100M
Astria Therapeutics, Inc.'s revenue is estimated to be in the range of $50M$100M
Company Leadership
A. K.Chief Commercial Officer (cco)- C. M.Chief Medical Officer
K. M.Chief Human Resources Officer- A. M.Chief Business Officer
N. C.Chief Financial Officer
Employee Directory
- A. N.Chief Scientific Officer
- B. H.Chief Legal Officer
- B. H.Senior Vice President And Chief Legal Officer
- J. D.Chief Medical Officer
- G. M.Vice President, Head Of Early Clinical Development
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
